Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Me's proprietary Precision Microbiome Profiling (PMP™) platform enables rapid, high-resolution and high-throughput analysis of the gut microbiome with demonstrated clinical utility in cancer immunotherapy response prediction, bone mineral density studies, and pediatric IBD diagnostics. The company is generating large-scale datasets from population biobanks (e.g., HUNT study) and has validated their TOPOSCORE bacterial signature for immunotherapy response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Me.